These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13413679)

  • 21. [The Thibierge- Weissenbach syndrome. Sclerodermatomyositis with generalized calcinosis].
    Alemà G; Merigliano D; Scarinci A
    Riv Neurol; 1965; 35(5):488-507. PubMed ID: 5884368
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thibierge-Weissenbach syndrome].
    Wrzask J; Michalski W
    Pol Tyg Lek; 1969 Dec; 24(49):1902-3. PubMed ID: 5369045
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thibierge-Weissenbach syndrome--a variant of calcinosis--in systemic scleroderma].
    Savenkova ND; Verzhenskaia EM; Korovnikova VA
    Pediatriia; 1985 Aug; (8):69-71. PubMed ID: 4069897
    [No Abstract]   [Full Text] [Related]  

  • 24. [Unusual, tumor-like calcinosis in scleroderma. Thibièrge-Weissenbach syndrome].
    Meyer E; Kulenkampff HA; Kortenhaus H
    Radiologe; 1987 Dec; 27(12):572-5. PubMed ID: 3438462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Calcification in scleroderma (contribution to the so-called Thiebierge-Weissenbach syndrome)].
    Kolár J; Drugová B; Stáva Z
    Sb Lek; 1971 Oct; 73(10):258-63. PubMed ID: 5137493
    [No Abstract]   [Full Text] [Related]  

  • 26. [Subcutaneous calcifications. A case of Thibierge-Weissenbach syndrome].
    Tournay R
    Phlebologie; 1975; 28(4):565-8. PubMed ID: 1221440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Thibierge-Weissenbach syndrome].
    Shevliakov LV
    Vestn Dermatol Venerol; 1968 Jun; 42(6):83. PubMed ID: 5747782
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the therapy of systematized scleropathy (progressive scleroderma) and systematized sarcoidosis with the chelating agent Na2EDTA].
    LANGHOF H; ZABEL H
    Dtsch Gesundheitsw; 1962 Feb; 17():188-97. PubMed ID: 14462154
    [No Abstract]   [Full Text] [Related]  

  • 29. [Physicochemical analysis of subcutaneous calcifications in a case of Thibierge-Weissenbach syndrome].
    Legros R; Puech J; Bonel G; Bossavy E; Bazex J; Averous S
    Ann Dermatol Venereol; 1986; 113(6-7):535-40. PubMed ID: 3813406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Unusual form of systemic scleroderma: Thibierge-Weissenbach or the "C.R.S.T. syndrome"].
    Ball M; Strobel M; Ndiaye B; Marchand JP
    Dakar Med; 1981; 26(3):309-14. PubMed ID: 7338128
    [No Abstract]   [Full Text] [Related]  

  • 31. [Progressive scleroderma in the atrophic phase associated with Raynaud and Thibierge-Weissenbach syndromes].
    ZAMFIR D; SAVIN A; HERCZEG E
    Bull Soc Fr Dermatol Syphiligr; 1960; 67():885-7. PubMed ID: 13787806
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hepatosplenic sclerosis and the Thibierge-Weissenbach syndrome].
    Grilliat JP; Rauber G; Laurent J; Drouin P
    Presse Med (1893); 1967 Oct; 75(44):2235-6. PubMed ID: 6077723
    [No Abstract]   [Full Text] [Related]  

  • 33. [THIBIERGE-WEISSENBACH SYNDROME].
    HADIDA E; STREIT R; SAYAG J
    Bull Soc Fr Dermatol Syphiligr; 1964; 71():410-1. PubMed ID: 14195329
    [No Abstract]   [Full Text] [Related]  

  • 34. [1st therapeutic trials of "chelating agents" (EDTA) in cases of scleroderma and of other fibrosclerotic processes of the dermal connective tissues].
    AGOSTINI A; ZANCA A
    G Ital Dermatol; 1961; 102():85-106. PubMed ID: 13859615
    [No Abstract]   [Full Text] [Related]  

  • 35. [Destruction of the saddle joint in scleroderma with multiple calcium deposits (Thibièrge-Weissenbach syndrome)].
    Helbig B; Ulrich HW
    Handchir Mikrochir Plast Chir; 1985 Nov; 17 Suppl():53-5. PubMed ID: 4076864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcinosis, Raynaud's phenomenon, sclerodactyly, and telangiectasia. The CRST syndrome.
    Schimke RN; Kirkpatrick CH; Delp MH
    Arch Intern Med; 1967 Apr; 119(4):365-70. PubMed ID: 6022520
    [No Abstract]   [Full Text] [Related]  

  • 37. [Progressive scleroderma with considerable electromyographical changes treated with chelating agents (E.D.T.A.)].
    da FONSECA
    J Med (Oporto); 1960 Feb; 41():469-76. PubMed ID: 13823810
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of Thibierge-Weissenbach syndrome].
    Kakhn KhA; Shamardin NA; Liĭn LA
    Vestn Rentgenol Radiol; 1969; 44(3):88-9. PubMed ID: 5366682
    [No Abstract]   [Full Text] [Related]  

  • 39. [THIBIERGE-WEISSENBACH SYNDROME].
    FERNANDEZDELVALLADO P; GIJONBANOS J; SORO JM; SANZMARTIN F
    Rev Clin Esp; 1964 Feb; 92():189-92. PubMed ID: 14151562
    [No Abstract]   [Full Text] [Related]  

  • 40. [Polyarthritis & generalized scleroderma of the Thibierge-Weissenbach type].
    FEROND M; DUMOULIN J
    J Belge Med Phys Rhumatol; 1959; 14(2):61-5. PubMed ID: 13654241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.